Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives $16.20 Average Target Price from Analysts

Integral Ad Science Holding Corp. (NASDAQ:IAS) has received a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $15.70.

A number of equities research analysts recently weighed in on IAS shares. Raymond James boosted their price objective on Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Piper Sandler reduced their price objective on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research report on Wednesday. Truist Financial reduced their price objective on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday. Craig Hallum reduced their price objective on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, Morgan Stanley boosted their price objective on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 23rd.

Integral Ad Science Price Performance

Integral Ad Science stock opened at $10.11 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.76 and a current ratio of 3.71. Integral Ad Science has a 52 week low of $7.98 and a 52 week high of $17.53. The stock has a market capitalization of $1.64 billion, a P/E ratio of 50.55, a price-to-earnings-growth ratio of 1.46 and a beta of 1.52. The stock has a fifty day moving average of $11.09 and a 200-day moving average of $10.47.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $133.50 million during the quarter, compared to analysts’ expectations of $138.06 million. During the same quarter in the previous year, the firm earned ($0.09) EPS. Integral Ad Science’s revenue was up 11.0% on a year-over-year basis. On average, sell-side analysts expect that Integral Ad Science will post 0.25 earnings per share for the current fiscal year.

Insider Buying and Selling at Integral Ad Science

In related news, CFO Tania Secor sold 6,643 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $11.24, for a total transaction of $74,667.32. Following the transaction, the chief financial officer now directly owns 251,366 shares of the company’s stock, valued at approximately $2,825,353.84. This represents a 2.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Lisa Utzschneider sold 10,481 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 23,006 shares of company stock valued at $240,296. 2.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Point72 DIFC Ltd acquired a new position in Integral Ad Science during the third quarter worth $41,000. nVerses Capital LLC purchased a new stake in shares of Integral Ad Science in the third quarter valued at about $45,000. Ameritas Investment Partners Inc. raised its holdings in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Integral Ad Science in the third quarter valued at about $106,000. Finally, Stoneridge Investment Partners LLC purchased a new stake in shares of Integral Ad Science in the third quarter valued at about $125,000. Institutional investors and hedge funds own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.